Hepcidin TH1-5

General Information


DRACP ID  DRACP01104

Peptide Name   Hepcidin TH1-5

Sequence  GIKCRFCCGCCTPGICGVCCRF

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Skin Secretion of the African Frog, Kassina senegalensis

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=20 μg/mL MTT assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01104

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H153N29O24S8

Absent amino acids  ADEHLMNQSWY

Common amino acids  C

Mass  270469

Pl  8.21

Basic residues  3

Acidic residues  0

Hydrophobic residues  5

Net charge  3

Boman Index  -412

Hydrophobicity  100

Aliphatic Index  48.64

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  500

Absorbance 280nm  23.81

Polar residues  13

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Hepcidin TH1-5 Induces Apoptosis and Activate Caspase-9 in MCF-7 Cells

Doi 10.7324/JAPS.2016.60211

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.